您当前的位置:
首页 >
文章列表页 >
Analysis of Treatment of Diabetic Kidney Disease with Modified Buyang Huanwutang Based on 5hmC-Seal Sequencing Technology
更新时间:2025-05-07
    • Analysis of Treatment of Diabetic Kidney Disease with Modified Buyang Huanwutang Based on 5hmC-Seal Sequencing Technology

      增强出版
    • The research team of the Department of Endocrinology of Peking University Third Hospital used 5hmC Seal sequencing technology and network pharmacology to chemically cut Buyang Huanwu Decoction, improve its therapeutic effect on diabetes nephropathy, and provide new ideas for mining Chinese medicines.
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 11, Pages: 208-217(2025)
    • DOI:10.13422/j.cnki.syfjx.20250514    

      CLC: R692;R285;R289
    • Received:19 March 2025

      Accepted:09 April 2025

      Published Online:10 April 2025

      Published:05 June 2025

    移动端阅览

  • ZHEN Baixin,CHEN Haoyu,MAIMAITIYASEN Duolikun,et al.Analysis of Treatment of Diabetic Kidney Disease with Modified Buyang Huanwutang Based on 5hmC-Seal Sequencing Technology[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(11):208-217. DOI: 10.13422/j.cnki.syfjx.20250514.

  •  
  •  

0

Views

91

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Mechanism of Buyang Huanwutang in Inhibiting Ferroptosis and Enhancing Neurological Function Recovery After Spinal Cord Injury via GPX4-ACSL4 Axis
Effect of Serum Containing Buyang Huanwutang on Podocytes Induced by High Glucose in Mice
Effect of Yiqi Huoxue Prescription on cAMP/Epac1/Rap1 Signaling Pathway in Coronary Heart Disease Rats with Qi Deficiency and Blood Stasis Syndrome
Danggui Buxuetang-containing Serum Alleviates Endoplasmic Reticulum Stress in Diabetic Kidney Disease to Inhibit Podocyte Apoptosis via PERK/ATF4/CHOP Pathway
Danggui Buxuetang Inhibits Mitochondrial Fission and Apoptosis of Podocytes in Rat of Diabetic Kidney Disease via AKAP1/Drp1 Signaling Pathway

Related Author

XU Luchun
JIANG Guozheng
MA Yukun
SONG Jiawei
GAO Yushan
WANG Guanlong
FAN Jiaojiao
YANG Yongdong

Related Institution

Japan Friendship Hospital
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine
Dongzhimen Hospital, Beijing University of Chinese Medicine
The First Affiliated Hospital of Hebei University of Chinese Medicine
Graduate School, Hebei University of Chinese Medicine
0